Netmed Inc
OTC:NTME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oi Electric Co Ltd
TSE:6822
|
JP |
Netmed Inc
Research & Development
Netmed Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Netmed Inc
OTC:NTME
|
Research & Development
-$52k
|
CAGR 3-Years
39%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Research & Development
-$251.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Netmed Inc
Glance View
NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.
See Also
What is Netmed Inc's Research & Development?
Research & Development
-52k
USD
Based on the financial report for Jun 30, 2002, Netmed Inc's Research & Development amounts to -52k USD.
What is Netmed Inc's Research & Development growth rate?
Research & Development CAGR 5Y
19%
Over the last year, the Research & Development growth was 59%. The average annual Research & Development growth rates for Netmed Inc have been 39% over the past three years , 19% over the past five years .